President Trump on Tuesday night bashed a "slow and burdensome approval process" at the Food and Drug Administration that he said keeps too many new drugs from reaching the market.
In an address to a joint session of Congress, Trump made a goal to speed up agency approval of new products. Trump has repeatedly called for the FDA to speed up approval of new drugs. However, he has yet to name a commissioner for the agency.
Trump in his prepared remarks pointed to a rare disease survivor, Megan Crowley, who was diagnosed with a serious illness, Pompe Disease, when she was 5 years old.
Crowley's father founded a company to find a cure and helped develop the drug that saved her life. Crowley is now a 20-year-old sophomore at the University of Notre Dame.
"Megan's story is about the unbounded power of a father's love for a daughter," Trump said.
He said the FDA approval process "keeps too many advances, like the one that saved Megan's life, from reaching those in need. If we slash restraints, not just at the FDA but across our government, then we will be blessed with far more miracles like Megan."
Trump also pledged to "work to bring down the artificially high price of drugs and bring them down immediately."
He didn't offer any specifics on which policy reforms should be adopted, however.
Democrats called on Trump to adopt a bill introduced Tuesday that would allow Americans to buy cheaper drugs from Canada.